ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs MXN
16.8987
-0.05%
Brent Oil
83.58
0.86%
Bitcoin
62,135.58
-0.32%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ARCA Biopharma Inc (ABIO)

  7. ARCA Biopharma Inc (ABIO) Noticias

ABIO

ARCA Biopharma (ABIO)

ARCA Biopharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ABIO
FechaHoraFuenteTítuloSímboloCompañía
25/04/202415:15GlobeNewswire Inc.ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
05/04/202412:09PR Newswire (US)Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
03/04/202406:30GlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
07/02/202412:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABIOARCA Biopharma Inc
06/02/202415:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
01/02/202415:35GlobeNewswire Inc.ARCA biopharma Announces 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
01/02/202415:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABIOARCA Biopharma Inc
31/01/202417:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
19/12/202315:25Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ABIOARCA Biopharma Inc
19/12/202315:20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ABIOARCA Biopharma Inc
19/12/202315:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABIOARCA Biopharma Inc
18/10/202315:25GlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
18/10/202315:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
11/09/202315:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABIOARCA Biopharma Inc
21/07/202315:25GlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
24/04/202315:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
24/04/202315:25GlobeNewswire Inc.ARCA biopharma Announces First Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
24/04/202315:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABIOARCA Biopharma Inc
24/02/202315:22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ABIOARCA Biopharma Inc
24/02/202315:20GlobeNewswire Inc.ARCA biopharma Announces 2022 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
19/12/202215:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABIOARCA Biopharma Inc
19/12/202215:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ABIOARCA Biopharma Inc
19/12/202215:05GlobeNewswire Inc.James Flynn Joins ARCA biopharma Board of DirectorsNASDAQ:ABIOARCA Biopharma Inc
03/11/202215:26Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ABIOARCA Biopharma Inc
03/11/202215:19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ABIOARCA Biopharma Inc
28/10/202215:15GlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2022 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
02/08/202215:15GlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2022 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
08/07/202215:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ABIOARCA Biopharma Inc
21/06/202215:05GlobeNewswire Inc.Jacob Ma-Weaver Joins ARCA biopharma Board of DirectorsNASDAQ:ABIOARCA Biopharma Inc
05/05/202215:15GlobeNewswire Inc.ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options ReviewNASDAQ:ABIOARCA Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABIO

Su Consulta Reciente

CCOM
OILBRENT
Brent Oil
COIN
BTCUSD
Bitcoin
FX
EURMXN
Euro vs MXN
NYSE
DIS
Walt Disney
NYSE
CVX
Chevron
NASDAQ
AMZN
Amazon.com
NYSE
AXP
American Express
NASDAQ
QQQ
Invesco QQQ Trust Series 1
SPI
SP500
S&P 500
NYSE
NKE
Nike
FX
EURUSD
Euro vs US Dollar
NASDAQ
GOOGL
Alphabet
CCOM
US500
US 500
FX
USDMXN
US Dollar vs MXN
USI
USTECH100
US Tech 100
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados